In conclusion, low‐risk criteria of 6MWD > 400 m and NT‐proBNP < 300 pg/mL according to 2015 ESC/ERS guidelines were significantly associated with less AEs in PAH‐CHD patients during one‐year follow‐up. This evidence concerns the gene NPPB and pulmonary arterial hypertension.